|
covid-19 |
89 |
|
chinese |
68 |
|
interprofessional education |
60 |
|
hong kong |
52 |
|
quality of life |
51 |
|
primary care |
45 |
|
health-related quality of life |
42 |
|
sars-cov-2 |
41 |
|
mortality |
40 |
|
social interaction anxiety |
40 |
|
covid-19 vaccine |
39 |
|
mental health |
36 |
|
diabetes mellitus |
35 |
|
stroke |
34 |
|
type 2 diabetes mellitus |
34 |
|
epidemiology |
32 |
|
humans |
32 |
|
validity |
31 |
|
bnt162b2 |
29 |
|
coronavac |
29 |
|
male |
29 |
|
reliability |
29 |
|
vaccine safety |
29 |
|
adult |
28 |
|
cardiovascular diseases |
28 |
|
diabetes |
28 |
|
hypertension |
28 |
|
partnership model |
28 |
|
questionnaires |
28 |
|
covid-19 vaccines |
27 |
|
medical sciences |
27 |
|
aged |
26 |
|
depression |
26 |
|
female |
26 |
|
cancer |
25 |
|
middle aged |
24 |
|
atrial fibrillation |
23 |
|
cardiovascular disease |
23 |
|
responsiveness |
23 |
|
screening |
22 |
|
complications |
21 |
|
heart failure |
21 |
|
nomogram |
21 |
|
primary health care |
21 |
|
risk stratification |
21 |
|
low-income families |
19 |
|
type 2 diabetes |
19 |
|
adolescent |
18 |
|
anxiety |
18 |
|
inactivated vaccine |
18 |
|
physical activity |
18 |
|
self-controlled case series |
18 |
|
sf-12 |
18 |
|
vaccination |
18 |
|
adolescents |
17 |
|
cohort study |
17 |
|
colorectal cancer |
17 |
|
evaluation |
17 |
|
prevalence |
17 |
|
psychometrics |
17 |
|
adult learning principles |
16 |
|
china |
16 |
|
collaborative practice |
16 |
|
dementia |
16 |
|
hong kong - epidemiology |
16 |
|
randomized controlled trial |
16 |
|
risk factors |
16 |
|
children |
15 |
|
cost-effectiveness |
15 |
|
empathy |
15 |
|
microvascular complications |
15 |
|
nursing |
15 |
|
vaccine effectiveness |
15 |
|
construct validation |
14 |
|
coronavirus infection |
14 |
|
cross-sectional studies |
14 |
|
general practice |
14 |
|
health outcomes |
14 |
|
metformin |
14 |
|
pre-diabetes |
14 |
|
safety |
14 |
|
systematic review |
14 |
|
vaccine |
14 |
|
variability |
14 |
|
antivirals |
13 |
|
blood pressure |
13 |
|
cardiovascular complications |
13 |
|
cardiovascular magnetic resonance |
13 |
|
cost |
13 |
|
curriculum |
13 |
|
hemoglobin a1c |
13 |
|
ischemic stroke |
13 |
|
myocardial infarction |
13 |
|
myocarditis |
13 |
|
patient-reported outcomes |
13 |
|
pericarditis |
13 |
|
preventive medicine |
13 |
|
public health |
13 |
|
quality of care |
13 |
|
reproducibility of results |
13 |
|
stress |
13 |
|
tuberculosis |
13 |
|
adverse events |
12 |
|
attitudes |
12 |
|
child health |
12 |
|
chronic kidney disease |
12 |
|
confirmatory factor analysis |
12 |
|
innate immunity |
12 |
|
service utilization |
12 |
|
validation |
12 |
|
antibiotics |
11 |
|
education, medical, undergraduate - methods |
11 |
|
family medicine |
11 |
|
health policy |
11 |
|
health status |
11 |
|
hospitalisation |
11 |
|
hrqol |
11 |
|
machine learning |
11 |
|
management |
11 |
|
mediation |
11 |
|
omicron |
11 |
|
patient acceptance of health care |
11 |
|
prediction model |
11 |
|
prognosis |
11 |
|
qualitative |
11 |
|
sexual health |
11 |
|
asian continental ancestry group - statistics & numerical data |
10 |
|
autoimmune disorders |
10 |
|
bidirectional relationship |
10 |
|
chronic disease |
10 |
|
communication |
10 |
|
delirium |
10 |
|
elderly |
10 |
|
family practice |
10 |
|
health empowerment |
10 |
|
incident cvd |
10 |
|
infection |
10 |
|
long covid |
10 |
|
major adverse cardiovascular events |
10 |
|
medicine |
10 |
|
meta-analysis |
10 |
|
parental stress |
10 |
|
pasc |
10 |
|
physician-patient relations |
10 |
|
post-acute sequelae of sars-cov-2 |
10 |
|
post-covid cvd |
10 |
|
problem-based learning - methods |
10 |
|
psychometric |
10 |
|
risk assessment |
10 |
|
sex difference |
10 |
|
smoking cessation |
10 |
|
young adult |
10 |
|
adverse events of special interest (aesi) |
9 |
|
all-cause mortality |
9 |
|
anchor |
9 |
|
attitude |
9 |
|
chest x-ray |
9 |
|
china - ethnology |
9 |
|
end stage renal disease |
9 |
|
fact-c |
9 |
|
general diabetes |
9 |
|
health sciences |
9 |
|
health surveys |
9 |
|
health-related quality of life (hrqol) |
9 |
|
influenza vaccines - administration and dosage |
9 |
|
knowledge |
9 |
|
mass screening |
9 |
|
mental disorders |
9 |
|
molnupiravir |
9 |
|
myocardial infarction - mortality - prevention and control |
9 |
|
nirmatrelvir-ritonavir |
9 |
|
osteoporosis |
9 |
|
patient-centered care |
9 |
|
pediatrics |
9 |
|
pharmacovigilance |
9 |
|
pharmacy |
9 |
|
pneumococcal vaccines - administration and dosage |
9 |
|
problem solving |
9 |
|
risk |
9 |
|
risk prediction model |
9 |
|
self-care enablement |
9 |
|
sensitivity |
9 |
|
stroke - mortality - prevention and control |
9 |
|
undergraduate |
9 |
|
undergraduate students |
9 |
|
vaccination - methods |
9 |
|
viral disease |
9 |
|
waning vaccine effectiveness |
9 |
|
white cell count |
9 |
|
4d flow |
8 |
|
adolescent idiopathic scoliosis |
8 |
|
adverse events of special interest |
8 |
|
aged, 80 and over |
8 |
|
assessment |
8 |
|
blood pressure variability |
8 |
|
ckd |
8 |
|
cohort |
8 |
|
cohort studies |
8 |
|
continuity of care |
8 |
|
curriculum - standards |
8 |
|
direct flow |
8 |
|
direct medical cost |
8 |
|
dpp4 |
8 |
|
early detection |
8 |
|
economic burden |
8 |
|
ehr |
8 |
|
emulated trial |
8 |
|
eq-5d-5l |
8 |
|
family doctor |
8 |
|
health |
8 |
|
hfpef |
8 |
|
incidence |
8 |
|
interventions |
8 |
|
intimate partner violence |
8 |
|
intraventricular flow |
8 |
|
management programme |
8 |
|
medical education |
8 |
|
medical humanities |
8 |
|
men who have sex with men |
8 |
|
mrna vaccine |
8 |
|
nonrestorative sleep |
8 |
|
odds ratio |
8 |
|
older patients |
8 |
|
pediatric population |
8 |
|
pneumococcal vaccination |
8 |
|
psychometric properties |
8 |
|
recurrent cardiovascular events |
8 |
|
rehabilitation |
8 |
|
residual volume |
8 |
|
risk prediction |
8 |
|
risk prediction score |
8 |
|
risky sexual behaviours |
8 |
|
screen time |
8 |
|
sf-6d |
8 |
|
sleep duration |
8 |
|
thyroidectomy |
8 |
|
age factors |
7 |
|
analgesia |
7 |
|
asia |
7 |
|
asian continental ancestry group |
7 |
|
aspirin |
7 |
|
autoclave |
7 |
|
behavior |
7 |
|
cardiovascular disease risk |
7 |
|
child behaviour |
7 |
|
child maltreatment |
7 |
|
clinic |
7 |
|
colorectal neoplasm |
7 |
|
consultation |
7 |
|
cost-of-illness |
7 |
|
cross-cultural comparison |
7 |
|
data collection |
7 |
|
decision making |
7 |
|
dental |
7 |
|
dialysis |
7 |
|
dialysis patients |
7 |
|
early onset scoliosis |
7 |
|
early onset scoliosis-24 questionnaire |
7 |
|
eosq-24 |
7 |
|
eq-5d |
7 |
|
family well-being |
7 |
|
fracture |
7 |
|
glycated haemoglobin |
7 |
|
health care service provider |
7 |
|
health economic analysis |
7 |
|
health literacy |
7 |
|
health preference |
7 |
|
health services |
7 |
|
health utility |
7 |
|
indirect effect |
7 |
|
information sharing |
7 |
|
intimate partner abuse |
7 |
|
learning |
7 |
|
lifestyle |
7 |
|
lower urinary tract symptoms |
7 |
|
men |
7 |
|
metabolic syndrome |
7 |
|
mobile apps |
7 |
|
morphine consumption |
7 |
|
multidisciplinary |
7 |
|
musculoskeletal disorders |
7 |
|
non-steroidal anti-inflammatory drugs |
7 |
|
nsaids |
7 |
|
patient enablement |
7 |
|
patient-reported outcome |
7 |
|
peritoneal dialysis |
7 |
|
placebo |
7 |
|
prediabetes |
7 |
|
prediabetic state |
7 |
|
prevention |
7 |
|
preventive measures |
7 |
|
psychiatric status rating scales |
7 |
|
qualitative research |
7 |
|
quality in health care |
7 |
|
quality of life - psychology |
7 |
|
quality-of-life |
7 |
|
questionnaires - standards |
7 |
|
rct |
7 |
|
renal replacement therapy |
7 |
|
sex education |
7 |
|
sf-36 |
7 |
|
short form-12 health survey version 2 (sf-12v2) |
7 |
|
spa |
7 |
|
spondyloarthritis |
7 |
|
sterilization |
7 |
|
urology |
7 |
|
visit‐to‐visit variability |
7 |
|
youth |
7 |
|
adolescent development |
6 |
|
angiotensin receptor blockers |
6 |
|
angiotensinconverting enzyme inhibitors |
6 |
|
asymptomatic |
6 |
|
automated |
6 |
|
barriers |
6 |
|
bifactor |
6 |
|
bmi |
6 |
|
cardiovascular health |
6 |
|
cardiovascular mortality |
6 |
|
child behavior |
6 |
|
clinical competence - standards |
6 |
|
corticosteroids |
6 |
|
cost effectiveness |
6 |
|
covid-19 incidence |
6 |
|
cross-sectional study |
6 |
|
cvd |
6 |
|
diagnosis |
6 |
|
dipeptidyl peptidase-4 inhibitors |
6 |
|
effectiveness |
6 |
|
end-stage renal disease |
6 |
|
facilitators |
6 |
|
family breakfast |
6 |
|
family dinner |
6 |
|
family functioning |
6 |
|
family meal |
6 |
|
film |
6 |
|
follow-up studies |
6 |
|
gastroenterology |
6 |
|
gastrointestinal tumours |
6 |
|
glucagon-like peptide-1 receptor agonists |
6 |
|
haemoglobin a1c |
6 |
|
hba1c |
6 |
|
hdl‐c |
6 |
|
health disparities |
6 |
|
health status indicators |
6 |
|
healthy eating |
6 |
|
high cardiovascular risk |
6 |
|
hong kong (香港) |
6 |
|
housing |
6 |
|
income instability |
6 |
|
influenza |
6 |
|
influenza virus |
6 |
|
information technology |
6 |
|
insulin |
6 |
|
intensive care unit |
6 |
|
intercalation enrichment year |
6 |
|
interpersonal relations |
6 |
|
intubation |
6 |
|
item response theory |
6 |
|
item selection |
6 |
|
job loss |
6 |
|
ldl‐c |
6 |
|
learning experience |
6 |
|
life expectancy |
6 |
|
lipids |
6 |
|
lipids variability |
6 |
|
low income |
6 |
|
measurement invariance |
6 |
|
medical student |
6 |
|
mental concentration |
6 |
|
mixed-method study |
6 |
|
mode of administration |
6 |
|
mortality risk |
6 |
|
motor difficulty |
6 |
|
nasopharyngeal |
6 |
|
nocturnal home haemodialysis |
6 |
|
online learning |
6 |
|
optimal test assembly |
6 |
|
parenting |
6 |
|
point-of-care testing |
6 |
|
prediction |
6 |
|
quality of health care |
6 |
|
radioactive iodine |
6 |
|
reflective thinking |
6 |
|
respiratory syncytial virus |
6 |
|
risk algorithm |
6 |
|
saliva |
6 |
|
sglt2 inhibitor |
6 |
|
sodium-glucose co-transporter |
6 |
|
sodium-glucose cotransporter-2 inhibitors |
6 |
|
stress cardiac magnetic resonance |
6 |
|
studiesmortality |
6 |
|
thirdhand smoke |
6 |
|
treatment |
6 |
|
type 2 diabetes mellitus (t2dm) |
6 |
|
undergraduate medicine curriculum |
6 |
|
undiagnosed diabetes |
6 |
|
volume–outcome |
6 |
|
volume–quality |
6 |
|
adenosine triphosphate |
5 |
|
adolescence |
5 |
|
aging |
5 |
|
air-sampler |
5 |
|
alertness |
5 |
|
androgen deficiency |
5 |
|
anti-bacterial agents - therapeutic use |
5 |
|
antibody |
5 |
|
booster |
5 |
|
canagliflozin |
5 |
|
cellular phone |
5 |
|
chatting |
5 |
|
chinese medicine;multi-centre |
5 |
|
clinical competence |
5 |
|
community centre |
5 |
|
community smoker |
5 |
|
competing risks |
5 |
|
coronary artery disease |
5 |
|
coronary heart disease |
5 |
|
costing analysis |
5 |
|
dapagliflozin |
5 |
|
database research |
5 |
|
dating apps |
5 |
|
depressive disorder - diagnosis - epidemiology |
5 |
|
detection |
5 |
|
drivers |
5 |
|
droplet |
5 |
|
drug repurposing |
5 |
|
economic evaluation |
5 |
|
education |
5 |
|
electronic frailty index |
5 |
|
empowerment |
5 |
|
enalapril |
5 |
|
endocrinology |
5 |
|
end‐ |
5 |
|
end‐stage renal disease |
5 |
|
environmental quality |
5 |
|
eq-5d-5 l |
5 |
|
fact-p |
5 |
|
family doctors |
5 |
|
follow - up care |
5 |
|
general population |
5 |
|
geriatric assessment - methods |
5 |
|
group discussion |
5 |
|
haemodialysis |
5 |
|
health knowledge, attitudes, practice |
5 |
|
health related quality of life |
5 |
|
health services research |
5 |
|
healthcare costs |
5 |
|
heart disease |
5 |
|
hepatitis b |
5 |
|
hiv prevention |
5 |
|
hong kong chinese population |
5 |
|
hospital |
5 |
|
human |
5 |
|
humanities |
5 |
|
hybrid immunity |
5 |
|
hypertension (ht) |
5 |
|
infectious diseases |
5 |
|
influenza vaccination |
5 |
|
inhalation |
5 |
|
instant messaging |
5 |
|
instrument |
5 |
|
interferons |
5 |
|
intervention |
5 |
|
kap |
5 |
|
logistic models |
5 |
|
magnetically controlled growing rod |
5 |
|
mapping |
5 |
|
mcgr |
5 |
|
medical education & training |
5 |
|
medical students |
5 |
|
medication safety |
5 |
|
mental disorders - diagnosis - epidemiology - psychology |
5 |
|
mental illness |
5 |
|
morbidity |
5 |
|
multi-disciplinary |
5 |
|
multidisciplinary-risk-assessment-and-management-programme |
5 |
|
myopericarditis |
5 |
|
nocturia |
5 |
|
non-communicable disease |
5 |
|
obesity |
5 |
|
orofacial pain |
5 |
|
orphan drug designation |
5 |
|
patient acceptance of health care - statistics & numerical data |
5 |
|
patient satisfaction |
5 |
|
patient‐reported outcome |
5 |
|
peer teaching |
5 |
|
pharmacoepidemiolgy |
5 |
|
physician encounters |
5 |
|
physiology |
5 |
|
pilot projects |
5 |
|
population norm |
5 |
|
population-based cohort |
5 |
|
postmarketing surveillance |
5 |
|
practice-based research network |
5 |
|
predictive value of tests |
5 |
|
predictors |
5 |
|
primary care (基層醫療) |
5 |
|
primary health care - methods |
5 |
|
prostate cancer |
5 |
|
protocol |
5 |
|
psychological distress |
5 |
|
pulmonary hypertension |
5 |
|
quality of health care - standards |
5 |
|
random survival forest (rsf) |
5 |
|
recurrence |
5 |
|
relapse prevention |
5 |
|
renal complications |
5 |
|
risk factor |
5 |
|
risk–benefit trade-off |
5 |
|
sacubitril/valsartan |
5 |
|
self-management |
5 |
|
sexually transmitted infection |
5 |
|
sf-12v2 |
5 |
|
short-message service |
5 |
|
sleep quality |
5 |
|
sodium-glucose co-transporter 2 inhibitor |
5 |
|
sports medicine |
5 |
|
stage renal disease |
5 |
|
stigma |
5 |
|
structured education |
5 |
|
survival |
5 |
|
t cell |
5 |
|
teaching |
5 |
|
temporal trend |
5 |
|
text messaging |
5 |
|
tgr |
5 |
|
thiazolidinediones |
5 |
|
thypro-39 |
5 |
|
traditional growing rod |
5 |
|
transmission |
5 |
|
treatment outcome |
5 |
|
unintentional injury |
5 |
|
young age of onset |
5 |
|
全科医生 |
5 |
|
access to health care |
4 |
|
accident and emergency department attendances |
4 |
|
active transport |
4 |
|
acute disease |
4 |
|
acute liver injury |
4 |
|
acute wound |
4 |
|
adam questionnaire |
4 |
|
adults |
4 |
|
analysis of variance |
4 |
|
androgens - blood - deficiency |
4 |
|
andropause |
4 |
|
anti-diabetic drug |
4 |
|
antithyroid drugs |
4 |
|
anxiety - epidemiology |
4 |
|
arrhythmias |
4 |
|
arrhythmogenic right ventricular cardiomyopathy/dysplasia |
4 |
|
asian continental ancestry group - statistics and numerical data |
4 |
|
asians |
4 |
|
association |
4 |
|
attitude of health personnel |
4 |
|
attitude to health |
4 |
|
automobile driving |
4 |
|
bariatric surgery |
4 |
|
big data |
4 |
|
biostatistics |
4 |
|
bodily pain |
4 |
|
breast neoplasms - diagnosis - economics - ethnology |
4 |
|
brugada syndrome |
4 |
|
cardiac |
4 |
|
cardiovascular diseases - epidemiology |
4 |
|
cardiovascular risk factors |
4 |
|
case series |
4 |
|
cd26 |
4 |
|
chemsex |
4 |
|
chest pain - epidemiology - psychology |
4 |
|
chinese medicine |
4 |
|
chinese men |
4 |
|
chlamydia |
4 |
|
chronic hepatitis b |
4 |
|
chronic liver disease |
4 |
|
chronic wound |
4 |
|
clinical audit |
4 |
|
clinical competence/*standards |
4 |
|
clinical consultation |
4 |
|
cognitive congruence |
4 |
|
collective efficacy |
4 |
|
colonoscopy |
4 |
|
community-based learning |
4 |
|
community-based medical education |
4 |
|
conservative treatment |
4 |
|
cost-benefit analysis |
4 |
|
cost‐effectiveness |
4 |
|
count data |
4 |
|
curriculum/ *standards |
4 |
|
depolarization |
4 |
|
depression - epidemiology |
4 |
|
depressive disorder |
4 |
|
depressive disorders |
4 |
|
diabetes complication |
4 |
|
diabetes mellitus - epidemiology |
4 |
|
diabetes mellitus, type 2 |
4 |
|
dipeptidyl-peptidase iv inhibitors |
4 |
|
double-blind method |
4 |
|
dpp4-inhibitor |
4 |
|
dpp4i |
4 |
|
dyspepsia - diagnosis |
4 |
|
dyspeptic patients |
4 |
|
ecg |
4 |
|
edoxaban |
4 |
|
education, medical, undergraduate - standards |
4 |
|
education, medical, undergraduate/*standards |
4 |
|
electronic health records |
4 |
|
emergency services |
4 |
|
empirical endoscopy |
4 |
|
endoscopy - economics - methods |
4 |
|
european continental ancestry group - statistics & numerical data |
4 |
|
exercise |
4 |
|
expectation |
4 |
|
eye diseases - diagnosis |
4 |
|
eye disorders |
4 |
|
factor analysis, statistical |
4 |
|
faculty, medical |
4 |
|
family physicians |
4 |
|
fecal occult blood testing |
4 |
|
female sex workers |
4 |
|
focus groups |
4 |
|
fractures, bone |
4 |
|
gastroesophageal reflux - epidemiology - psychology |
4 |
|
general practitioner |
4 |
|
genetic susceptibility |
4 |
|
gliptin |
4 |
|
good hrqol |
4 |
|
gout |
4 |
|
graves’ disease |
4 |
|
h pylori test-and treat |
4 |
|
health care system |
4 |
|
health education - methods |
4 |
|
health enablement |
4 |
|
health professions students |
4 |
|
health seeking |
4 |
|
health service |
4 |
|
health services - utilization |
4 |
|
health utilization |
4 |
|
helicobacter infections - diagnosis |
4 |
|
helicobacter pylori - metabolism |
4 |
|
hepatitis b, chronic - physiopathology |
4 |
|
hepatitis b, chronic - psychology |
4 |
|
hip fracture |
4 |
|
home blood pressure monitoring |
4 |
|
hong kong chinese |
4 |
|
hospital admissions |
4 |
|
hospitalization |
4 |
|
hrqol data |
4 |
|
hrqol outcome |
4 |
|
hrqol score |
4 |
|
hyperinflammatory syndrome |
4 |
|
hypogonadism - diagnosis - ethnology |
4 |
|
idiopathic scoliosis |
4 |
|
impaired fasting glucose |
4 |
|
in-hospital death |
4 |
|
incontinence |
4 |
|
instrument development |
4 |
|
insulin therapy |
4 |
|
integrative medicine |
4 |
|
internal medicine |
4 |
|
internet |
4 |
|
latent variable |
4 |
|
longitudinal study |
4 |
|
macrovascular disease |
4 |
|
mammography |
4 |
|
mammography - economics |
4 |
|
mass screening - economics - methods |
4 |
|
measurement |
4 |
|
medical ethics |
4 |
|
mental disorders - therapy |
4 |
|
metabolic syndrome x - epidemiology |
4 |
|
mhealth interventions |
4 |
|
micro-costing |
4 |
|
microvascular disease |
4 |
|
model recalibration |
4 |
|
morbidity survey |
4 |
|
multi-morbidity |
4 |
|
multidisciplinary intervention |
4 |
|
needs assessment |
4 |
|
neutrophil-to-lymphocyte ratio |
4 |
|
nirmatrelvir/ritonavir |
4 |
|
nonnegative matrix factorization |
4 |
|
norm |
4 |
|
nurse practitioners urology |
4 |
|
obesity - epidemiology |
4 |
|
osteoporotic |
4 |
|
outcomes research methods |
4 |
|
outpatient clinics |
4 |
|
papillary thyroid carcinoma |
4 |
|
parent-child interaction |
4 |
|
patient education |
4 |
|
patient-centred care |
4 |
|
peritoneal dialysis first |
4 |
|
person-centered primary care |
4 |
|
physicians - psychology |
4 |
|
population based cohort |
4 |
|
practice guidelines |
4 |
|
practice guidelines as topic |
4 |
|
practice-based research |
4 |
|
predictive model |
4 |
|
predictor |
4 |
|
preference |
4 |
|
primary care physicians |
4 |
|
primary medical care |
4 |
|
priming |
4 |
|
problem solving treatment |
4 |
|
professional drivers |
4 |
|
proton pump inhibition |
4 |
|
psychology |
4 |
|
psychometric testing |
4 |
|
psychotherapy, brief - methods - standards |
4 |
|
quality assurance |
4 |
|
quality criteria |
4 |
|
quality in healthcare |
4 |
|
quality of life (qol) |
4 |
|
questionnaire |
4 |
|
ramp-dm |
4 |
|
randomised controlled trial |
4 |
|
recurrent laryngeal nerve |
4 |
|
regression analysis |
4 |
|
repolarization |
4 |
|
resilience |
4 |
|
retrospective study |
4 |
|
risk assessment and management |
4 |
|
risk estimation |
4 |
|
risk judgment |
4 |
|
risk management |
4 |
|
risk score |
4 |
|
risk stratification, dementia |
4 |
|
robotic thyroidectomy |
4 |
|
self-management education |
4 |
|
sensitivity and specificity |
4 |
|
sexualised drug use |
4 |
|
sexuality |
4 |
|
sglt2 |
4 |
|
smartphone application |
4 |
|
social congruence |
4 |
|
social media |
4 |
|
socio-economics factors |
4 |
|
sodium-glucose cotransporter 2 inhibitors |
4 |
|
sodium-glucose transporter 2 inhibitors |
4 |
|
southern chinese |
4 |
|
statin |
4 |
|
student facilitator |
4 |
|
student reflection |
4 |
|
substance use disorders |
4 |
|
suffering |
4 |
|
sulphonylurea |
4 |
|
survey |
4 |
|
tachycardia |
4 |
|
teachers |
4 |
|
team cohesiveness |
4 |
|
team collaboration |
4 |
|
teenagers |
4 |
|
testosterone |
4 |
|
testosterone - blood |
4 |
|
thyroid cancer |
4 |
|
thyroid nodule |
4 |
|
total thyroidectomy |
4 |
|
training |
4 |
|
trajectory |
4 |
|
type 2 diabetes, structured education |
4 |
|
uk biobank |
4 |
|
ultrasonography |
4 |
|
undiagnosed dm |
4 |
|
ventricular |
4 |
|
ventricular arrhythmias |
4 |
|
ventricular fibrillation |
4 |
|
ventricular tachycardia |
4 |
|
vertebral fracture |
4 |
|
viral clearance |
4 |
|
warfarin |
4 |
|
wellbeing |
4 |
|
wound assessment |
4 |
|
young adults |
4 |
|
问卷调查 |
4 |
|
2-pyridinylmethylsulfinylbenzimidazoles |
3 |
|
5-level eq-5d |
3 |
|
acoustic analysis |
3 |
|
acquired long qt syndrome |
3 |
|
action potential duration |
3 |
|
action research |
3 |
|
activities of daily living |
3 |
|
addqol-19 |
3 |
|
age distribution |
3 |
|
ageing |
3 |
|
ageing male |
3 |
|
agreement |
3 |
|
alzheimer's disease |
3 |
|
analgesics - therapeutic use |
3 |
|
andrology |
3 |
|
anti-diabetic drugs |
3 |
|
anti-ulcer agents - administration & dosage |
3 |
|
antibiotic resistance |
3 |
|
antiviral activity |
3 |
|
anxiety - complications |
3 |
|
anxiety - etiology |
3 |
|
anxiety disorders - ethnology |
3 |
|
article |
3 |
|
associated factors |
3 |
|
atrial fibrillation - surgery |
3 |
|
attachment styles |
3 |
|
audit |
3 |
|
automated ecg |
3 |
|
back-specific |
3 |
|
bbq |
3 |
|
bed rest - adverse effects |
3 |
|
behaviour |
3 |
|
benign prostatic hyperplasia |
3 |
|
blended learning |
3 |
|
bother |
3 |
|
bracing |
3 |
|
brugada |
3 |
|
cardiovascular events |
3 |
|
catheter ablation |
3 |
|
catheter ablation - methods |
3 |
|
central lymph nodes |
3 |
|
central neck dissection |
3 |
|
cervical myelopathy |
3 |
|
cervical spondylotic myelopathy |
3 |
|
chest pain - epidemiology |
3 |
|
chi-square distribution |
3 |
|
child |
3 |
|
child abuse |
3 |
|
china - epidemiology |
3 |
|
chinese population |
3 |
|
choice behavior |
3 |
|
chronic obstructive pulmonary disease |
3 |
|
classification |
3 |
|
clinical assessment |
3 |
|
clinical examination |
3 |
|
clinical improvement |
3 |
|
clinical trial |
3 |
|
close friends |
3 |
|
cluster analysis |
3 |
|
cognitive dysfunction |
3 |
|
colonic diseases, functional - ethnology - psychology |
3 |
|
consultation rates |
3 |
|
consumer satisfaction |
3 |
|
controlled study |
3 |
|
coping strategies |
3 |
|
cosmin |
3 |
|
cost minimization |
3 |
|
cost-effectiveness analysis (ce) |
3 |
|
counseling |
3 |
|
cross-over studies |
3 |
|
cryosurgery - methods |
3 |
|
crystalline arthropathy |
3 |
|
culture |
3 |
|
curfew |
3 |
|
decision tree |
3 |
|
decompression |
3 |
|
deep learning |
3 |
|
delivery of care |
3 |
|
delphi technique |
3 |
|
depression - complications - psychology |
3 |
|
depressive disorder - complications |
3 |
|
depressive disorder - ethnology |
3 |
|
detrended fluctuation analysis |
3 |
|
diabetes care |
3 |
|
diabetes complications |
3 |
|
diabetes remission |
3 |
|
direct medical costs |
3 |
|
disability |
3 |
|
discrete choice experiment |
3 |
|
domestic violence |
3 |
|
dpp4 inhibitor |
3 |
|
drug prescriptions |
3 |
|
drug resistance, microbial |
3 |
|
drug utilization |
3 |
|
dyspepsia |
3 |
|
dyspepsia - ethnology - psychology |
3 |
|
dyspepsia - physiopathology |
3 |
|
dysphonia |
3 |
|
dyspnea - epidemiology |
3 |
|
editorial |
3 |
|
editorial policies |
3 |
|
education, medical - methods |
3 |
|
education, medical - organization & administration |
3 |
|
education, premedical - organization & administration |
3 |
|
educational measurement |
3 |
|
educational status |
3 |
|
elderly chinese |
3 |
|
enablers |
3 |
|
endoscopic |
3 |
|
endoscopic thyroidectomy |
3 |
|
entropy |
3 |
|
eortc qlq-c30 |
3 |
|
eq-5d-3l-y |
3 |
|
eq-5d-y |
3 |
|
estimated glomerular filtration rate (egfr) |
3 |
|
ethnography |
3 |
|
euroqol 5-dimension 5-level |
3 |
|
fabq |
3 |
|
facial muscles - physiopathology |
3 |
|
facial pain - classification - psychology |
3 |
|
facial pain - complications |
3 |
|
facial pain - complications - psychology |
3 |
|
facial pain - epidemiology - therapy |
3 |
|
facial pain - psychology - therapy |
3 |
|
family |
3 |
|
family factor |
3 |
|
family practice - education |
3 |
|
family practice - education - standards |
3 |
|
feasibility |
3 |
|
flat feet |
3 |
|
focussed ultrasound |
3 |
|
food preferences |
3 |
|
gastrectomy |
3 |
|
gastric acidity determination |
3 |
|
gastric bypass |
3 |
|
gastroesophageal reflux - diagnosis |
3 |
|
gastroesophageal reflux - drug therapy - ethnology |
3 |
|
gastroesophageal reflux - epidemiology |
3 |
|
gastroesophageal reflux - epidemiology - therapy |
3 |
|
gastroesophageal reflux - ethnology - etiology |
3 |
|
gender |
3 |
|
general practice (全科醫療) |
3 |
|
general practitioners |
3 |
|
genetic variants |
3 |
|
geriatric assessment - statistics & numerical data |
3 |
|
gps |
3 |
|
group dynamics |
3 |
|
headache - classification - psychology |
3 |
|
health behavior |
3 |
|
health personnel |
3 |
|
healthcare delivery |
3 |
|
healthcare utilisation |
3 |
|
healthcare utilization |
3 |
|
help-seeking willingness |
3 |
|
hepatitis c virus (hcv) |
3 |
|
heptanol |
3 |
|
history of medicine |
3 |
|
hiv |
3 |
|
homosexuality, male - psychology |
3 |
|
hong kong chinese adolescents |
3 |
|
hpv |
3 |
|
hydrogen-ion concentration |
3 |
|
hygiene practices |
3 |
|
hypoparathyroidism |
3 |
|
icd (implantable cardioverter-defibrillator) |
3 |
|
igt |
3 |
|
immigrant |
3 |
|
impact |
3 |
|
incentive |
3 |
|
income |
3 |
|
incremental cost-effectiveness ratio threshold |
3 |
|
index of electrophysiological balance |
3 |
|
inflammation |
3 |
|
inter-atrial block |
3 |
|
internet use |
3 |
|
interviews as topic |
3 |
|
intra-operative neuro-monitoring |
3 |
|
ipss |
3 |
|
irritable bowel syndrome - ethnology - etiology |
3 |
|
joacmeq |
3 |
|
latent class analysis |
3 |
|
letter |
3 |
|
linkage-to-care |
3 |
|
lockdown |
3 |
|
long qt syndrome |
3 |
|
longitudinal strain;mechanical dispersion |
3 |
|
low back pain |
3 |
|
lumbar spinal stenosis (lss) |
3 |
|
marriage |
3 |
|
mds-hc |
3 |
|
measurement property |
3 |
|
medical |
3 |
|
medicine, chinese traditional |
3 |
|
microsurgery |
3 |
|
migrants |
3 |
|
mitral regurgitation |
3 |
|
mitral stenosis |
3 |
|
mitral valve |
3 |
|
morbidity (發病) |
3 |
|
mouth diseases - classification - psychology |
3 |
|
myocardial repolarization |
3 |
|
national containment |
3 |
|
nerve monitoring |
3 |
|
neutrophil |
3 |
|
nodule shrinkage |
3 |
|
non-laboratory-based |
3 |
|
non-negative matrix factorization |
3 |
|
non-robotic thyroidectomy |
3 |
|
normoglycaemia |
3 |
|
novel predictor |
3 |
|
ogtt |
3 |
|
older adults |
3 |
|
omeprazole - administration & dosage - analogs & derivatives |
3 |
|
open suicide discussion |
3 |
|
opioid |
3 |
|
orofacial |
3 |
|
p-wave |
3 |
|
p-wave area |
3 |
|
p-wave duration |
3 |
|
paediatric quality of life inventory |
3 |
|
pain |
3 |
|
pain - complications - psychology |
3 |
|
pain measurement |
3 |
|
paresthesia - classification - psychology |
3 |
|
parkinson's disease |
3 |
